Harel Insurance Investments & Financial Services Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 659 shares of REGN stock, worth $462,519. This represents 0.01% of its overall portfolio holdings.

Number of Shares

659

Previous 393 67.68%

Holding current value

$462,519

Previous $413,000 67.8%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$1024.09 - $1201.76 $272,407 - $319,668	266 Added 67.68%	659 $693,000
Q2 2024 Jul 22, 2024	SELL	$883.2 - $1071.19 $255,244 - $309,573	-289 Reduced 42.38%	393 $413,000
Q1 2024 Apr 30, 2024	BUY	$902.69 - $993.35 $326,773 - $359,592	362 Added 113.13%	682 $656,000
Q4 2023 Jan 30, 2024	SELL	$775.18 - $881.7 $312,397 - $355,325	-403 Reduced 55.74%	320 $281,000
Q3 2023 Oct 30, 2023	BUY	$692.45 - $844.37 $257,591 - $314,105	372 Added 105.98%	723 $598,000
Q2 2023 Jul 17, 2023	SELL	$700.03 - $830.35 $2.31 Million - $2.74 Million	-3,294 Reduced 90.37%	351 $252,000
Q1 2023 May 02, 2023	SELL	$680.49 - $826.97 $1.59 Million - $1.93 Million	-2,338 Reduced 39.08%	3,645 $2.96 Million
Q4 2022 Jan 26, 2023	BUY	$705.89 - $766.39 $2.31 Million - $2.5 Million	3,268 Added 120.37%	5,983 $4.3 Million
Q3 2022 Oct 31, 2022	BUY	$573.97 - $724.32 $438,513 - $553,380	764 Added 39.16%	2,715 $1.88 Million
Q2 2022 Jul 19, 2022	BUY	$548.35 - $738.84 $1.04 Million - $1.4 Million	1,891 Added 3151.67%	1,951 $1.15 Million
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $1.44 Million - $1.69 Million	-2,418 Reduced 97.58%	60 $42,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $1.14 Million - $1.41 Million	2,106 Added 566.13%	2,478 $1.59 Million
Q3 2021 Oct 25, 2021	SELL	$574.03 - $680.96 $1.07 Million - $1.27 Million	-1,861 Reduced 83.34%	372 $225,000
Q2 2021 Jul 26, 2021	BUY	$472.8 - $558.54 $523,389 - $618,303	1,107 Added 98.31%	2,233 $4.07 Million
Q1 2021 Apr 27, 2021	SELL	$446.73 - $548.2 $228,725 - $280,678	-512 Reduced 31.26%	1,126 $1.78 Million
Q4 2020 Jan 26, 2021	BUY	$478.3 - $607.98 $62,657 - $79,645	131 Added 8.69%	1,638 $2.37 Million
Q3 2020 Oct 20, 2020	BUY	$544.75 - $658.21 $820,938 - $991,922	1,507 New	1,507 $844,000
Q2 2020 Jul 14, 2020	SELL	$493.32 - $643.92 $317,204 - $414,040	-643 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$336.18 - $494.43 $69,589 - $102,347	207 Added 47.48%	643 $314,000
Q4 2019 Jan 23, 2020	BUY	$274.13 - $376.51 $80,320 - $110,317	293 Added 204.9%	436 $164,000
Q2 2019 Jul 22, 2019	BUY	$299.6 - $414.82 $21,870 - $30,281	73 Added 104.29%	143 $45,000
Q1 2019 Apr 18, 2019	BUY	$372.08 - $439.57 $26,045 - $30,769	70 New	70 $29,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account

Harel Insurance Investments & Financial Services Ltd. Regeneron Pharmaceuticals, Inc. Transaction History